Capital Fund Management (CFM)’s CRISPR Therapeutics CRSP Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$4.56M Buy
+95,770
New +$5.05M 0.04% 936
2025
Q4
Hold
0
2492
2025
Q3
Hold
0
2566
2025
Q2
Hold
0
2447
2025
Q1
Sell
-18,097
Closed -$767K 2122
2024
Q4
$712K Sell
18,097
-32,007
-64% -$1.51M 0.01% 1836
2024
Q3
$2.35M Buy
+50,104
New +$2.54M 0.03% 1361
2024
Q2
Sell
-56,114
Closed -$3.25M 1987
2024
Q1
$3.82M Sell
56,114
-16,905
-23% -$1.21M 0.05% 1173
2023
Q4
$4.57M Buy
+73,019
New +$4.04M 0.06% 1129
2023
Q3
Sell
-42,026
Closed -$2.17M 2026
2023
Q2
$2.36M Buy
42,026
+29,785
+243% +$1.69M 0.04% 1125
2023
Q1
$554K Sell
12,241
-48,013
-80% -$2.33M 0.01% 1429
2022
Q4
$2.45M Buy
+60,254
New +$3.2M 0.05% 866
2022
Q3
Sell
-104,142
Closed -$7.55M 1484
2022
Q2
$6.33M Sell
104,142
-114,730
-52% -$6.74M 0.17% 448
2022
Q1
$13.7M Buy
218,872
+129,831
+146% +$8.15M 0.37% 261
2021
Q4
$6.75M Sell
89,041
-36,926
-29% -$3.23M 0.18% 526
2021
Q3
$14.1M Buy
125,967
+111,461
+768% +$14M 0.37% 267
2021
Q2
$2.35M Sell
14,506
-6,397
-31% -$778K 0.06% 871
2021
Q1
$2.55M Buy
+20,903
New +$3.16M 0.09% 667
2020
Q4
Sell
-10,858
Closed -$908K 1363
2020
Q3
$908K Buy
+10,858
New +$963K 0.03% 901
2020
Q2
Sell
-7,035
Closed -$411K 1158
2020
Q1
$298K Buy
7,035
+3,565
+103% +$184K 0.01% 1228
2019
Q4
$211K Buy
+3,470
New +$189K ﹤0.01% 1739
2019
Q1
Hold
0
1758
2018
Q4
Sell
-34,040
Closed -$1.18M 1932
2018
Q3
$1.51M Buy
+34,040
New +$1.78M 0.02% 1228

Other funds holding CRSP